What You Should Know:
- Transcarent and Prescryptive Health announced today a partnership to provide the industry’s most immersive, intelligent, and individualized pharmacy care experience.
- Transcarent Pharmacy Care empowers Transcarent Members and their families with an entirely different consumer-directed experience that truly transforms their health and care journey and provides, for the first time, employers and health systems with maximum control over their formulary, benefit
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Ascensia Launches Diabetes Management and Analytics Platform in the U.S
What You Should Know:
- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® blood glucose monitoring (BGM) system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring (CGM) Systems, has launched its online diabetes management and analytics platform GlucoContro.online in the United States.
- Now available in more than 15 countries globally and in the process of further expansion, GlucoContro.online support diabetes management by
Read More
AI ‘s Role in Drug Discovery: Separating the Hype from the Hope
Forecasting the influence that artificial intelligence (AI)/machine learning technologies will have on the future of healthcare has created a cottage industry in the hype. From the overzealous aspirations of IBM’s Watson Health initiative to the inclusion of AI on Gartner’s 2021 Hype Cycle at the “Peak of Inflated Expectations,” so much noise has been made around AI/machine learning in healthcare that it can be difficult to appreciate the current impact of these technologies on drug discovery,
Read More
Report: Virtual Care Still in ‘Wild West’ Days Sparking Confusion, High Optimism, Investment
What You Should Know:
- A new "State of Virtual Care" report by Omada Health and Digital Medicine Society, in collaboration with Rock Health, reveals that buyers today are inundated with vendors labeling themselves “virtual care providers,” regardless of the care model they’re selling. This phenomenon is blurring their perception of V1C’s potential impact, and what that means for improvements in healthcare delivery and outcomes.
- V1C solutions like Omada Health are changing the market,
Read More
Numares Health & Mayo Clinic Expands AI-Enabled Diagnostic Testing Collaboration
What You Should Know:
- Mayo Clinic and Numares Health have expanded their collaboration recently to develop AI-enabled diagnostic testing that is more accurate and reliable than current U.S. tests for patients with chronic diseases, including kidney, cardiovascular, liver and neurologic conditions.
- The expanded collaboration builds on Mayo Clinic's clinical research support for Numares Health to include an innovative convertible equity investment.
AI-Enabled
Read More
Parkview Health Launches Virtual Care Offering, Powered by Veta Health
What You Should Know:
- Veta Health announced today the launch of its virtual care offering at Parkview Health (Parkview), a not-for-profit, Indiana-based network of 10 hospitals and more than 100 clinics.
- In partnership with Veta Health, Parkview will offer its patients virtual care programs designed to support patient recovery and self-management at home. The initial focus is utilizing Veta Health’s patient engagement, device-based monitoring, and telehealth tools to manage patients
Read More
Valera Health Secures $45M to Increase Mental Health Access for High Acuity Patients
What You Should Know:
Valera Health, a virtual mental health provider serving high acuity patients raises $44.5M in growth equity raise led by Heritage Group.
The round also included participation from Cigna Ventures, Horizon Healthcare Services and existing investors, which include Windham Ventures, AXA Venture Partners, Aquiline Technology Partners, Trinnovate Ventures (BCBS AZ), Figure Eight Investments, Watershed VC, and Alsora Capital.
Care that is comprehensive, inclusive, and
Read More
Carta Healthcare Secures $20M for AI-Enabled Clinical Data Solutions
What You Should Know:
- Carta Healthcare, a pioneer in harnessing the power of clinical data, today announced it closed a $20 million series B round led by South Korean firm Paramark Ventures. Other contributors to the round include Memorial Care Innovation Fund (MCIF) and Frist Cressey Ventures, led by heart surgeon, incoming chair of The Nature Conservancy’s Board of Directors and former U.S. Senate Majority Leader Bill Frist.- Carta will use the
Read More
JPMorgan Establishes Life Sciences Private Equity Division
What You Should Know:
- J.P. Morgan Asset Management announced the establishment of a new life sciences private equity team, Life Sciences Private Capital.
- The new team will focus on investing in both early and growth-stage healthcare companies across multiple strategies aligned to specific market opportunities, with a focus on novel therapeutics and technologies in several target areas including Genetic Medicine, Oncology, Neurodegenerative Disease, Rare Diseases, Autoimmunity,
Read More
Research: Proscia AI Predicts Diagnostic Agreement for Melanoma
What You Should Know:
- Proscia® a provider of digital and computational pathology solutions, has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer.
- The findings, which were presented at the European Conference on Computer Vision (ECCV) 2022, highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases with low pathologist concordance.
Findings
Read More
